V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310002682 | 310001136 | 1.8 | 83.4 | Curative (C) | 2014-10-02 | 2014-10-02 | Cisplatin | N | N | 310015784 | CISPLATIN |
| 310002683 | 310001137 | 1.78 | 89.55 | Palliative (P) | 2018-11-16 | 2018-11-16 | Trial Unspecified | N | null | 310015785 | TRIAL |
| 310002684 | 310001138 | 1.58 | 53 | Curative (C) | 2013-03-03 | 2013-03-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310015793 | CISPLATIN + GEMCITABINE |
| 310002686 | 310001140 | 1.69 | null | Palliative (P) | 2017-09-28 | 2017-09-30 | PEMBROLIZUMAB | 02 | N | 310015801 | PEMBROLIZUMAB |
| 310002687 | 310001140 | 0 | 58 | Curative (C) | 2013-10-12 | 2013-10-26 | Retinoblastoma JOE | N | N | 310015801 | CEV |
| 310002689 | 310001141 | 1.7 | null | Palliative (P) | 2016-09-20 | 2016-09-20 | CHEMO-T TRIAL | 01 | null | 310015825 | TRIAL |
| 310002690 | 310001141 | 1.9 | 102.9 | Adjuvant (A) | 2013-03-12 | 2013-03-13 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310015825 | CISPLATIN + GEMCITABINE |
| 310002691 | 310001141 | 1.73 | 67.4 | Curative (C) | 2013-04-04 | 2013-04-04 | Cisplatin | 02 | Y | 310015825 | CISPLATIN |
| 310002692 | 310001142 | 1.62 | 72 | Curative (C) | 2017-09-24 | 2017-09-24 | CHOP R - 21 days | N | N | 310015836 | CHOP R |
| 310002693 | 310001142 | null | 81 | Palliative (P) | 2016-01-24 | 2016-01-24 | PEMBROLIZUMAB | N | N | 310015836 | PEMBROLIZUMAB |
| 310002694 | 310001142 | 1.63 | 70.3 | Palliative (P) | 2013-09-11 | 2013-09-19 | Ipilimumab | N | N | 310015836 | IPILIMUMAB |
| 310002695 | 310001143 | 0 | null | Curative (C) | 2015-07-29 | 2015-08-02 | Retinoblastoma JOE | N | null | 310015853 | CEV |
| 310002696 | 310001144 | null | null | Adjuvant (A) | 2014-07-04 | 2014-07-30 | Retinoblastoma JOE | N | N | 310015858 | CEV |
| 310002697 | 310001145 | 1.57 | null | Palliative (P) | 2018-05-25 | 2018-06-03 | Ipilimumab | 02 | N | 310015859 | IPILIMUMAB |
| 310002700 | 310010266 | 1.75 | 81 | null | 2015-05-22 | 2015-05-22 | CISPLATIN + GEMCITABINE | N | N | 310015862 | CISPLATIN + GEMCITABINE |
| 310002701 | 310011006 | 1.8 | 55.1 | Curative (C) | 2014-04-06 | 2014-04-08 | Cisplatin 7 day | N | N | 310015863 | CISPLATIN |
| 310002702 | 310001146 | 1.72 | 77 | Curative (C) | null | 2017-12-23 | CISPLATIN + GEMCITABINE | N | N | 310015864 | CISPLATIN + GEMCITABINE |
| 310002703 | 310001146 | null | null | Curative (C) | null | 2013-06-12 | Retinoblastoma JOE | N | null | 310015864 | CEV |
| 310002704 | 310008939 | 1.8 | 96 | Disease modification (D) | 2013-06-29 | 2013-06-29 | Cisplatin | null | N | 310015871 | CISPLATIN |
| 310002705 | 310010267 | 1.7 | 11.5 | Palliative (P) | null | 2013-05-02 | DOXORUBICIN | N | N | 310015877 | DOXORUBICIN |
| 310002706 | 310001147 | 1.86 | 80 | Palliative (P) | 2018-07-18 | 2018-07-18 | Trial Unspecified | 02 | N | 310015889 | TRIAL |
| 310002707 | 310001148 | 0 | 85.5 | Curative (C) | 2013-10-14 | 2013-10-30 | Retinoblastoma JOE | N | N | 310015890 | CEV |
| 310002708 | 310001149 | 1.68 | null | Palliative (P) | 2014-05-08 | 2014-05-14 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310015894 | CISPLATIN + GEMCITABINE |
| 310002709 | 310001150 | 1.74 | 7.2 | Palliative (P) | 2017-04-22 | 2017-04-25 | DOXORUBICIN | N | N | 310015897 | DOXORUBICIN |
| 310002710 | 310006432 | 1.59 | 61.4 | Palliative (P) | 2017-08-06 | 2017-08-22 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310015898 | CISPLATIN + GEMCITABINE |
| 310002711 | 310001151 | 1.76 | 99.9 | Palliative (P) | 2013-07-05 | 2013-07-17 | PEMBROLIZUMAB | N | N | 310015902 | PEMBROLIZUMAB |
| 310002712 | 310001152 | 1.68 | 129 | Palliative (P) | 2013-10-13 | 2013-10-22 | Cisplatin | N | N | 310015906 | CISPLATIN |
| 310002713 | 310001153 | 1.72 | 62.2 | Palliative (P) | 2014-06-29 | 2014-07-03 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310015909 | CISPLATIN + GEMCITABINE |
| 310002714 | 310001154 | 1.56 | 7 | Palliative (P) | 2017-04-30 | 2017-04-30 | Ipilimumab | 2 | N | 310015910 | IPILIMUMAB |
| 310002715 | 310001154 | 1.77 | 82 | Palliative (P) | 2013-07-24 | 2013-08-09 | CISPLATIN + GEMCITABINE | N | N | 310015910 | CISPLATIN + GEMCITABINE |
| 310002716 | 310001155 | 1.8 | 92.5 | Palliative (P) | 2017-01-22 | 2017-01-26 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 310015914 | CISPLATIN + GEMCITABINE |
| 310002717 | 310006434 | 1.7 | 14.5 | Palliative (P) | 2018-06-10 | 2018-06-13 | Ipilimumab | N | null | 310015915 | IPILIMUMAB |
| 310002718 | 310006434 | 1.63 | 82.6 | Palliative (P) | 2014-06-07 | 2014-06-14 | Trial Unspecified | Y | N | 310015915 | TRIAL |
| 310002719 | 310006434 | 1.86 | 98.3 | Curative (C) | 2014-06-29 | 2014-07-15 | Cisplatin 7 day | 02 | Y | 310015915 | CISPLATIN |
| 310002720 | 310001156 | 1.81 | 96.2 | Curative (C) | 2013-04-01 | 2013-04-18 | Cisplatin | null | Y | 310015926 | CISPLATIN |
| 310002721 | 310001157 | null | 17 | Palliative (P) | 2014-11-27 | 2014-12-11 | Ipilimumab | 02 | N | 310015928 | IPILIMUMAB |
| 310002722 | 310001157 | null | null | Palliative (P) | 2017-02-25 | 2017-03-16 | Ipilimumab | 02 | N | 310015928 | IPILIMUMAB |
| 310002723 | 310008941 | null | 90 | Adjuvant (A) | 2014-12-30 | 2015-01-01 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310015938 | CISPLATIN + GEMCITABINE |
| 310002724 | 310008941 | null | 60.1 | Curative (C) | 2016-01-24 | 2016-01-24 | Cisplatin | N | N | 310015938 | CISPLATIN |
| 310002725 | 310008941 | null | null | Palliative (P) | 2017-06-26 | 2017-07-12 | CARBOPLATIN + ETOPOSIDE | N | N | 310015938 | CARBOPLATIN + ETOPOSIDE |
| 310002726 | 310001158 | 1.63 | 60 | Palliative (P) | 2013-11-22 | 2013-11-24 | Trial Unspecified | Y | N | 310015947 | TRIAL |
| 310002727 | 310001158 | 1.52 | 69 | Curative (C) | 2016-05-23 | 2016-05-27 | Trial Unspecified | 01 | N | 310015947 | TRIAL |
| 310002728 | 310001159 | 1.86 | 80 | Palliative (P) | 2017-01-21 | 2017-01-26 | Cisplatin+Gemcitabine (Days 1&8&15) | N | N | 310015951 | CISPLATIN + GEMCITABINE |
| 310002729 | 310001160 | 1.53 | null | Palliative (P) | 2014-06-15 | 2014-07-07 | Cisplatin+Gemcitabine (gallbladder) | N | N | 310015954 | CISPLATIN + GEMCITABINE |
| 310002730 | 310006437 | null | 58.5 | Palliative (P) | 2017-08-17 | 2017-08-17 | Ipilimumab | N | N | 310015960 | IPILIMUMAB |
| 310002731 | 310001161 | 1.8 | 75.6 | Palliative (P) | 2016-12-06 | 2016-12-28 | Carboplatin + Etoposide iv&po | N | N | 310015961 | CARBOPLATIN + ETOPOSIDE |
| 310002732 | 310006438 | 1.84 | 96.8 | Palliative (P) | 2014-03-09 | 2014-03-25 | Ipilimumab | N | N | 310015963 | IPILIMUMAB |
| 310002733 | 310008942 | 1.85 | 80.75 | Curative (C) | 2015-03-04 | 2015-03-16 | CHOP R - 21 days | N | N | 310015965 | CHOP R |
| 310002734 | 310001162 | null | null | Curative (C) | 2017-10-14 | 2017-10-24 | CHOP R - 21 days | N | N | 310015967 | CHOP R |
| 310002735 | 310001162 | 1.75 | 98 | Palliative (P) | 2014-12-22 | 2014-12-25 | CARBOPLATIN + ETOPOSIDE | 02 | N | 310015967 | CARBOPLATIN + ETOPOSIDE |